Heterophile Antigens

Subscribe to Selected New Research on Heterophile Antigens

129 relevant articles (6 outcomes, 8 trials/studies) found for this Bio-Agent

Description: Antigens stimulating the formation of, or combining with heterophile antibodies. They are cross-reacting antigens found in phylogenetically unrelated species.

Also Known As:

Antigens, Heterophile; Antigens, Heterologous; Antigens, Heterophil; Antigens, Xenogenic; Heterogenetic Antigens; Antigens, H-D; Antigens, Hanganutziu-Deicher; Antigens, Paul-Bunnell; H D Antigens; Hanganutziu Deicher Antigens; Heterophil Antigens; Paul Bunnell Antigens; Xenogeneic Antigens; Xenogenic Antigens; Antigens, Heterogenetic; Antigens, Xenogeneic; H-D Antigens; Hanganutziu-Deicher Antigens; Heteroantigens; Heterologous Antigens; Paul-Bunnell Antigens; Xenoantigens

Relationship Network

Bio-Agent Context: Research Results

Biological Factors: 931

Antigens: 95584

Heterophile Antigens: 129

Forssman Antigen: 27

Experts

1.	Collioud, Andre: 1 article (01/2007)
2.	Goebel, Werner: 1 article (01/2007)
3.	Spreng, Simone: 1 article (01/2007)
4.	Fensterle, Joachim: 1 article (01/2007)
5.	Sieber, Heike: 1 article (01/2007)
6.	Mollet, Fabian: 1 article (01/2007)
7.	Gentschev, Ivaylo: 1 article (01/2007)
8.	Pearman, Jon: 1 article (01/2007)
9.	Rothen, Simon A: 1 article (01/2007)
10.	Griot-Wenk, Monika E: 1 article (01/2007)

Related Diseases

1.	Infection 06/01/2008 - "Human and animal studies suggest that infection with these intestinal nematodes is associated with impaired cellular immunity, characterized by reduced lymphocyte proliferation in response to both parasite and heterologous antigens. " 01/01/2007 - "Although the presented results are preliminary and additional study of more sera of people infected with Salmonella Typhi is needed, it can be concluded after Chart et al., that an immunoblotting procedure incorporating O=9,12 LPS and flagellar H=d antigens is a useful method for providing serological evidence of infection with Salmonella Typhi. " 02/01/2009 - "Because of this homology, heterologous antigens have been used in the immunodiagnosis and vaccine development against Leishmania infections. " 01/01/2009 - "This infection process results in the stimulation of strong innate and adaptive immune responses, which make it an ideal candidate for a vaccine vector to deliver heterologous antigens. " 12/01/2006 - "In most cases, Puumala and Dobrava virus infections could be differentiated by ELISA reactivity alone, i.e., endpoint titration with homologous and heterologous antigens." Order ALL the reference details at left...
2.	Typhoid Fever (Typhoid) 01/01/2007 - "Vivotif--a 'magic shield' for protection against typhoid fever and delivery of heterologous antigens." 10/01/2003 - "Advances in typhoid vaccination include promising preclinical and clinical trial results of recombinant ZH9 and CVD 908-htrA vaccines, which, in addition to providing protection against typhoid fever, may be useful vectors for heterologous antigens. " 01/01/1994 - "The successful development of a genetically defined oral typhoid vaccine will not only be a major step forward in the control of typhoid but will pave the way for development of practical human vaccines based on using the strain to deliver heterologous antigens to the human immune system. " Order ALL the reference details at left...
3.	Neoplasms (Cancer) 09/01/2005 - "In the case of cervical cancer, human papillomavirus (HPV) xenoantigens are readily recognised by the immune system, and their targeting has shown great promise in preclinical models of therapeutic vaccination and in clinical studies of preventative vaccination. " 05/01/2009 - "METHODS: Sequential intratumoral injection of the xenoantigens was performed in immunized mice bearing S180 tumor. " 05/01/2009 - "OBJECTIVE:To investigate the therapeutic effect of sequential intratumoral injection of xenogeneic antigens in immunized tumor-bearing mice. " 01/01/2006 - "Furthermore, dendritic cells were able to prime tumor immunity when pulsed with the placental xenoantigens. " 10/01/2004 - "This "one-size-fits-it-all"-feature of Yersinia-translocated heterologous antigens might be advantageous to mount T-cellular immune responses against complex microbes and tumors." Order ALL the reference details at left...
4.	Vaccinia 10/01/1994 - "In addition to the previously described ability of vaccinia to induce immune responses in experimental animals, the virus has been shown to encode modulators of immune function that may, in the future, permit the use of virus to induce qualitatively different immune responses to particular heterologous antigens." 09/01/2003 - "Originating from highly efficacious vaccines securing world-wide eradication of smallpox, the most appealing use of vaccinia vectors is to serve as vaccine delivery system for heterologous antigens. " Order ALL the reference details at left...
5.	Viremia 09/01/1982 - "Lactate dehydrogenase-elevating virus (LDV) causes a normally benign persistent infection of mice, resulting in a life-long viremia characterized by the presence of circulating infectious immune complexes, impaired clearance of certain enzymes from the blood, and modification of the host immune response to various heterologous antigens. " Order ALL the reference details at left...

Related Drugs and Biologics

1.	Vaccines
2.	Enzymes
3.	Antigen-Antibody Complex (Immune Complex)
4.	Antigens
5.	Antibodies
6.	Immunoglobulin G (IgG)
7.	Immunoglobulin M (IgM)
8.	Complement System Proteins (Complement)
9.	Heterophile Antigens
10.	Typhoid-Paratyphoid Vaccines (Typhoid Vaccines)

Related Therapies and Procedures

1.	Magic
2.	Transplantation (Transplant Recipients)
3.	Transplants (Transplant)
4.	Immunotherapy
5.	Homologous Transplantation (Allograft)

Best Treatments:
Research Summary Report
on Infection

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 14726 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>